miércoles, 15 de julio de 2020

Coronavirus Disease 2019 (COVID-19) | FDA

Coronavirus Disease 2019 (COVID-19) | FDA

FDA is taking an “all-hands-on-deck” approach to tackling this pandemic, and colleagues across the entire organization work tirelessly for the American people

FDA is taking an “all-hands-on-deck” approach to tackling this pandemic, and colleagues across the entire organization work tirelessly for the American people

Coronavirus Disease 2019 (COVID-19) Update

FDA is an active partner in the coronavirus disease (COVID-19) response, working closely with our government and public health partners across the U.S. Department of Health and Human Services, and with our international counterparts. Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last MCMi email update on July 8, 2020 include:

Coronavirus (COVID-19) Updates:

July 14, 2020: Daily Roundup: FDA actions on treatment acceleration, drug compounding, warning letters, hand-sanitizer quiz, therapeutics, and more
July 10, 2020: FDA prepares for resumption of domestic inspections with new risk assessment system
Also see the features and Emergency Use Authorization Updates below